|
| 37229174 | Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial. | Open Forum Infect Dis | 2023 |
| 37792612 | Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. | N Engl J Med | 2023 |
| 35219277 | Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial. | Clin Infect Dis | 2022 |
| 35895508 | Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19. | J Infect Dis | 2022 |
| 36255239 | Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies. | mBio | 2022 |
| 33097414 | Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial. | Clin Lung Cancer | 2021 |
| 33575203 | <i>nab</i>-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis. | Front Oncol | 2021 |
| 33643895 | <i>nab</i>-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+). | Front Oncol | 2021 |
| 34587383 | REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19. | N Engl J Med | 2021 |
| 34496013 | Baseline Severe Acute Respiratory Syndrome Viral Load Is Associated With Coronavirus Disease 2019 Severity and Clinical Outcomes: Post Hoc Analyses of a Phase 2/3 Trial. | J Infect Dis | 2021 |
| 33345430 | Analysis of the Role of Plasma 25-Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic Cancer. | Oncologist | 2021 |
| 33332778 | REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. | N Engl J Med | 2021 |
| 32228198 | Quality of life with second or third line <i>nab</i>-paclitaxel-based regimens in advanced non-small-cell lung cancer. | Future Oncol | 2020 |
| 32554514 | Open-label, Phase I Study of Nivolumab Combined with <i>nab</i>-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer. | Clin Cancer Res | 2020 |
| 30933354 | Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapy. | Cancer | 2019 |
| 31850192 | Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With <i>nab</i>-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer. | Front Oncol | 2019 |
| 31559379 | A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus <i>nab</i>-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer. | J Pancreat Cancer | 2019 |
| 29040030 | Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study. | J Clin Oncol | 2018 |
| 30383906 | ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC). | Cancer | 2018 |
| 28889792 | Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. | N Engl J Med | 2017 |
| 28915085 | Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma. | J Clin Oncol | 2017 |
| 28841387 | Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials. | J Clin Oncol | 2017 |
| 27025835 | 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens. | Clin Infect Dis | 2016 |
| 27188960 | On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir. | Liver Int | 2016 |
| 26683763 | Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis. | Liver Int | 2016 |
| 27009831 | All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study. | Liver Int | 2016 |
| 26822022 | Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+). | Hepatology | 2016 |
| 26155891 | High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms. | Adv Ther | 2015 |
| 24113732 | Clinical judgment does not circumvent the need for diagnostic endoscopy in upper gastrointestinal hemorrhage. | J Investig Med | 2013 |
| 22239101 | Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis. | AIDS Patient Care STDS | 2012 |
| 23023466 | Respiratory viruses identified in an urban children's hospital emergency department during the 2009 influenza A(H1N1) pandemic. | Pediatr Emerg Care | 2012 |
| 22734949 | Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008). | AIDS Patient Care STDS | 2012 |
| 22723341 | Indexing severity of diabetic foot infection with 99mTc-WBC SPECT/CT hybrid imaging. | Diabetes Care | 2012 |
| 22587392 | Solid organ transplant recipients presenting for Mohs micrographic surgery: a retrospective case-control study. | Dermatol Surg | 2012 |
| 20398960 | Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. | J Am Acad Dermatol | 2011 |
| 21941210 | Acute kidney injury and chronic kidney disease in hospitalized patients with cirrhosis. | J Investig Med | 2011 |
| 21962318 | The hematocrit level in upper gastrointestinal hemorrhage: safety of endoscopy and outcomes. | Am J Med | 2011 |
| 21516560 | Addressing multiplicity issues of a composite endpoint and its components in clinical trials. | J Biopharm Stat | 2011 |
| 21569165 | Is coronary computed tomography angiography a resource sparing strategy in the risk stratification and evaluation of acute chest pain? Results of a randomized controlled trial. | Acad Emerg Med | 2011 |
| 21284015 | Evaluation metrics for biostatistical and epidemiological collaborations. | Stat Med | 2011 |
| 21183616 | Corpus callosum length by gestational age as evaluated by fetal MR imaging. | AJNR Am J Neuroradiol | 2011 |
| 19892337 | Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer. | Int J Gynaecol Obstet | 2010 |
| 21098154 | Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. | Pediatrics | 2010 |
| 20682668 | Spondyloarthritis in a pediatric population: risk factors for sacroiliitis. | J Rheumatol | 2010 |
| 19409754 | Cardiovascular autonomic functions in well-controlled and intractable partial epilepsies. | Epilepsy Res | 2009 |